Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Psyence BioMed Announces Exclusive U.S. Ibogaine Licence for Texas Ibogaine Research Corporation

Binding term sheet with PsyLabs provides Psyence BioMed’s Texas subsidiary with exclusive U.S. development, supply and distribution rights to PsyLabs’ pharmaceutical-grade ibogaine, subject to a definitive agreement NEW YORK, Sept. 28, 2026 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”) today announced that its wholly-owned Texas subsidiary, Texas…

We haven't written up this one. Financial Post has the full story — the link below goes straight to it.

Read the original at financialpost.com →

More in Finance & Markets

U.S. Becomes South Korean Builders’ Top Overseas Market

The center of gravity for the overseas business of domestic construction companies is shifting to the United States. The proportion of the U.S.

  • U.S. tops overseas market for South Korean construction firms.
  • Orders more than double to $7.38 billion in first half.
  • Investments in energy sector drive growth, including nuclear and solar.

More from Monday 28 September →